KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Revenue (2017 - 2025)

Elanco Animal Health's Revenue history spans 9 years, with the latest figure at $1.1 billion for Q4 2025.

  • For Q4 2025, Revenue rose 12.16% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $4.7 billion, up 6.22%, while the annual FY2025 figure was $4.7 billion, 6.22% up from the prior year.
  • Revenue for Q4 2025 was $1.1 billion at Elanco Animal Health, up from $1.1 billion in the prior quarter.
  • Across five years, Revenue topped out at $1.3 billion in Q2 2021 and bottomed at $985.0 million in Q4 2022.
  • The 5-year median for Revenue is $1.1 billion (2025), against an average of $1.1 billion.
  • The largest annual shift saw Revenue soared 118.09% in 2021 before it decreased 11.42% in 2022.
  • A 5-year view of Revenue shows it stood at $1.1 billion in 2021, then decreased by 11.42% to $985.0 million in 2022, then grew by 5.08% to $1.0 billion in 2023, then fell by 1.45% to $1.0 billion in 2024, then grew by 12.16% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Revenue are $1.1 billion (Q4 2025), $1.1 billion (Q3 2025), and $1.2 billion (Q2 2025).